Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NR5A1 | Q13285 | 3/20 | 0.36 |
| ▸ | PTPN1 | P18031 | 2/20 | 0.34 |
| ▸ | LTA4H | P09960 | 1/20 | 0.34 |
| ▸ | NR5A2 | O00482 | 2/20 | 0.34 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.33 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.33 |
| ▸ | MEN1 | O00255 | 1/20 | 0.33 |
| ▸ | RECQL | P46063 | 1/20 | 0.33 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.33 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.33 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.33 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.33 |
| ▸ | SOAT1 | P35610 | 1/20 | 0.33 |
| ▸ | USP2 | O75604 | 1/20 | 0.32 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.32 |
| ▸ | CNR2 | P34972 | 1/20 | 0.32 |
| ▸ | FAAH | O00519 | 1/20 | 0.32 |
| ▸ | MGLL | Q99685 | 1/20 | 0.32 |
| ▸ | CHRM2 | P08172 | 3/20 | 0.32 |
| ▸ | CHRM4 | P08173 | 3/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10598620 | 0.99 | NR5A1 (0.38) | NR5A1PTPN1LTA4HNR5A2CYP2C9 | |
| SCHEMBL27696494 | 0.99 | NR5A1 (0.38) | NR5A1PTPN1LTA4HNR5A2CYP2C9 | |
| SCHEMBL10595491 | 0.99 | NR5A1 (0.38) | NR5A1PTPN1LTA4HNR5A2CYP2C9 | |
| SCHEMBL27467887 | 0.96 | USP2 (0.35) | NR5A1PTPN1LTA4HNR5A2CYP2C9 | |
| SCHEMBL8341789 | 0.93 | CNR2 (0.33) | NR5A1PTPN1LTA4HNR5A2CYP2C9 | |
| SCHEMBL10599698 | 0.91 | OPRM1 (0.32) | NR5A1NR5A2 | |
| SCHEMBL10597224 | 0.85 | — | — | |
| SCHEMBL27481820 | 0.85 | — | — | |
| SCHEMBL28858600 | 0.83 | NR5A1 (0.39) | NR5A1PTPN1LTA4HNR5A2CYP2C9 | |
| SCHEMBL10447189 | 0.82 | L3MBTL1 (0.35) | CYP2C9CYP2C19MEN1RECQLKMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-109574811-B | Preparation method of anidulafungin side chain intermediate p-pentoxy terphenyl formic acid | 中山大学 | 2021-12-24 | — | — | CN | claimed |
| CN-109574811-A | A kind of preparation method of anidulafungin side chain intermediate to amoxy terphenyl formic acid | 中山大学 | 2019-04-05 | — | — | CN | claimed |
| CN-113999083-A | Novel method for synthesizing 2, 2-difluoroethyl aromatic compound | 山东理工大学 | 2022-02-01 | — | — | CN | disclosed |
| CN-109574811-B | Preparation method of anidulafungin side chain intermediate p-pentoxy terphenyl formic acid | 中山大学 | 2021-12-24 | — | — | CN | disclosed |
| CN-109574811-B | Preparation method of anidulafungin side chain intermediate p-pentoxy terphenyl formic acid | 中山大学 | 2021-12-24 | — | — | CN | disclosed |
| CN-110872206-A | Reduction coupling method for synthesizing 1, 1-difluoroethyl aromatic compound | 山东理工大学 | 2020-03-10 | — | — | CN | disclosed |
| CN-109574811-A | A kind of preparation method of anidulafungin side chain intermediate to amoxy terphenyl formic acid | 中山大学 | 2019-04-05 | — | — | CN | disclosed |
| US-20030054981-A1 | Echinocandin pharmaceutical formulations containing micelle-forming surfactants | ELI LILLY AND COMPANY | 2003-03-20 | — | — | US | disclosed |
| CN-1345333-A | Echinocandin/carbohydrate complexes | LILLY CO ELI (US) | 2002-04-17 | — | — | CN | disclosed |
| WO-2001060395-A2 | METHODS OF TREATMENT FOR NON-INVASIVE FUNGUS-INDUCED MUCOSITIS WITH CYCLOHEXAPEPTIDE ANTIFUNGAL AGENTS | ELI LILLY AND COMPANY (US) | 2001-08-23 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030054981-A1 | Echinocandin pharmaceutical formulations containing micelle-forming surfactants | TREH, MPDU1, MAN1B1 | NR5A1 3910/4885PTPN1 1680/4885LTA4H 2207/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.